Xvivo Perfusion AB (0RKL)
Market Open
9 Dec, 15:53
LSE 
kr
176. 60
-7.3
-3.97%
kr
12.08B Market Cap
384.18 P/E Ratio
0% Div Yield
3,280 Volume
1.4 Eps
kr 183.9
Previous Close Day Range
176.6 183.45
Year Range
176.6 343.52
Want to track 0RKL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days
0RKL have yet to publish their earning reports.
0RKL Earnings Reports FAQ
What is the earnings per share (EPS) for 0RKL?
The current EPS is 1.4.
What is the company's earnings growth rate?
Over the past 1 years, the earnings growth rate has been approximately -80.99%, reflecting the 0RKL's performance and LSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-01-26, based on the 0RKL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.1375 per share, reported on 2025-10-23. For dividend history, visit the 0RKL Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 1,284.36, calculated based on the most recent stock price of kr176.60.
2025 © Marketlog. All Rights Reserved.
